Program Perspectives in Cell- and Gene-Based Medicines - DGTI
Program Perspectives in Cell- and Gene-Based Medicines - DGTI
Program Perspectives in Cell- and Gene-Based Medicines - DGTI
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Program</strong> Friday, March 16<br />
Friday, March 16<br />
Or2a.6<br />
13:00 - 13:12<br />
Hematopoietic stem cell fate control by Gadd45 gamma<br />
Frederic B. Thalheimer, Frankfurt<br />
Scientific Session 2b HZ 11<br />
11:00 - 13:15 Virotherapy <strong>and</strong> Cancer <strong>Gene</strong> Therapy<br />
Chairs: Dirk Nettelbeck, Heidelberg; Wolfgang Uckert, Berl<strong>in</strong><br />
Inv13<br />
11:00 - 11:30<br />
Inv14<br />
11:30 - 11:50<br />
Inv15<br />
11:50 - 12:10<br />
Or2b.1<br />
12:10 - 12:22<br />
Or2b.2<br />
12:22 - 12:34<br />
Or2b.3<br />
12:34 - 12:46<br />
Or2b.4<br />
12:46 - 12:58<br />
Or2b.5<br />
12:58 - 13:10<br />
Next generation enveloped viruses for oncolytic virotherapy<br />
Roberto Cattaneo, Rochester<br />
Parvoviruses as oncolytic pr<strong>in</strong>ciples <strong>in</strong> cancer treatment<br />
Jean Rommelaere, Heidelberg<br />
Improv<strong>in</strong>g the safety of T cell receptor gene therapy<br />
Wolfgang Uckert, Berl<strong>in</strong><br />
Lcmv-pseudotyped vsv-based systems for treatment<br />
of malignant glioma<br />
Alex<strong>and</strong>er Muik, Frankfurt<br />
Immunomodulatory transgene armed oncolytic measles virus<br />
<strong>in</strong>duces anti tumor immunity<br />
Christian Grossardt, Heidelberg<br />
Safety of oncolytic measles-virus-supercd <strong>in</strong> transgenic mice<br />
<strong>and</strong> rhesus macaques<br />
Iris Völker, Langen<br />
Exclusive T cell receptor gene transfer to human CD8+ T cells<br />
enhances tumor cell kill<strong>in</strong>g<br />
Qi Zhou, Langen<br />
<strong>Gene</strong>tic eng<strong>in</strong>eer<strong>in</strong>g comb<strong>in</strong>ed with directed evolution for<br />
develop<strong>in</strong>g efficient oncolytic adenoviruses<br />
Inés Fernández Ulibarri, Heidelberg<br />
Scientific Session 5 HZ 4<br />
11:00 - 13:15 <strong>Gene</strong>tic, Metabolic <strong>and</strong> Acquired Disorders<br />
Chairs: Johannes Oldenburg, Bonn; Jörg Schüttrumpf, Frankfurt<br />
Inv22<br />
11:00 - 11:22<br />
Inv23<br />
11:20 - 11:40<br />
<strong>Gene</strong> therapy for the treatment of <strong>in</strong>hibitor <strong>in</strong> hemophilia<br />
Valder Arruda, Philadelphia<br />
<strong>Gene</strong> therapy for diabetes<br />
Fatima Bosch, Barcelona<br />
20
Change language